People on the Move
Merck KGaA
Luciano Rossetti has taken up his post as Global Head of R&D at Merck KGaA’s biopharma division in Billerica, near Boston, Massachusetts. He will share his time between the Billerica R&D hub and Merck KGaA’s headquarters in Darmstadt, Germany.
Rosetti, aged 57, most recently held the role of Senior VP, Late Stage Development at Merck & Co. (Merck Sharp & Dohme). There, he was responsible for clinical development from Phase II onwards, across all treatment areas. At Merck & Co., he was involved in developing several compounds, including anti PD-1. He also restructured the clinical genetics group to improve collaboration between the discovery and clinical development departments.
What’s the difference between Merck KGaA and Merck & Co.? Click here for our interactive guide.